Unicycive Therapeutics Revenue

Revenue (ttm)

n/a

Revenue Growth

n/a

P/S Ratio

n/a

Revenue / Employee

n/a

Employees

Market Cap

109.47M

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	675.00K	-276.00K	-29.02%
Dec 31, 2022	951.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Protalix BioTherapeutics	76.38M
Compugen	72.66M
Arcturus Therapeutics Holdings	54.71M
Precision BioSciences	45.07M
MediWound	14.48M
Equillium	4.39M
Korro Bio	3.84M
Humacyte	2.02M

Revenue Rankings

UNCY News

20 minutes ago - Unicycive Therapeutics CRL tied to same vendor deficiency, says B. Riley - TheFly
3 hours ago - Unicycive Therapeutics receives complete response letter from FDA for OLC NDA - TheFly
4 hours ago - Unicycive Therapeutics Receives Complete Response Letter from FDA Regarding Resubmitted Oxylanthanum Carbonate (OLC) New Drug Application (NDA) - GlobeNewsWire
8 days ago - Unicycive Therapeutics Proxy statement: Proxy filing - Filings
24 days ago - Unicycive Therapeutics files $150M mixed securities shelf - TheFly
25 days ago - Unicycive Therapeutics Registration statement: Registration filing - Filings
26 days ago - Unicycive Therapeutics Slides: Corporate presentation - Filings
4 weeks ago - Unicycive Therapeutics price target raised to $18 from $15 at Benchmark - TheFly

More News